Misleading Anti-Yo Positivity on Immunoblot Alone: Importance of Rat-Brain Immunohistochemistry
Journal of Clinical Neurology · 2026 · 22 (3) · 384
DOI: 10.3988/jcn.2025.0695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Neurology, 2026. Verfasst von Jee Won Hong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Seoul National University College of Medicine, Seoul, Korea. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea.
Abstract (Originalsprache)
The anti-Yo antibody is an onconeural antibody which binds with the CDR2L, antigen of Purkinje cell cytoplasmic antibody type 1. 1 These onconeural antigens are expressed in both Purkinje cells and tumor cells, regarded as a paraneoplastic antibody, especially associated with ovarian and breast cancer. 1 Patients with anti-Yo antibody experience the death process of Purkinje cells via cytotoxic cellular immunity against CDR2L, eventually leading to para-neoplastic cerebellar degeneration (PCD). 1 Findings of this antibody are confirmed through two ways: immunoblot and rat cerebellar immunohistochemistry. Here, we report an educational case of false positive anti-Yo antibody misdiagnosed by a commercial immunoblot paraneoplastic neurologic assay, but ruled out by the rat-brain immunohistochemistry. A 29-year-old female was referred to the institution for the evaluation of paraneoplastic neurologic syndrome. She had a history of optic neuritis 27 months before presentation and experienced a sudden onset of right foot drop seven months before presentation. She had no neurological symptoms apart from the foot drop, and no specific treatment was administered for this condition. Nerve conduction study from the primary institution confirmed the compressive type of the peroneal palsy. Due to her history of optic neuritis, a paraneo-plastic antibody screening test was performed one month before presentation. The EURO-IMMUN immunoblot strip test revealed anti-Yo antibody positivity. She was referred to our institution for secondary opinion of paraneoplastic syndromes and additional work-up of underlying cancer. In neurologic examinations, she showed normal cognitive function, cerebellar function, and vision, but had right peroneal sensorimotor palsy. We repeated the EUROIMMUN immunoblot strip test to confirm the initial result, and also introduced the rat cerebellar immunohistochemistry
Autor:innen und Institutionen
- Department of Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. staelee@snu.ac.kr.
ORCID-Profile: Jee Won Hong, Chae Min Kang, Su Yee Mon, Soon-Tae Lee
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
Zitieren
APA
Hong, J. W., Kang, C. M., Mon, S. Y., & Lee, S. T. (2026). Misleading Anti-Yo Positivity on Immunoblot Alone: Importance of Rat-Brain Immunohistochemistry. Journal of Clinical Neurology, 22(3), 384. https://doi.org/10.3988/jcn.2025.0695
Vancouver
Hong JW, Kang CM, Mon SY, Lee ST. Misleading Anti-Yo Positivity on Immunoblot Alone: Importance of Rat-Brain Immunohistochemistry. Journal of Clinical Neurology. 2026;22(3):384. doi:10.3988/jcn.2025.0695
BibTeX
@article{Hong2026,
author = {Hong, Jee Won and Kang, Chae Min and Mon, Su Yee and Lee, Soon-Tae},
title = {Misleading Anti-Yo Positivity on Immunoblot Alone: Importance of Rat-Brain Immunohistochemistry},
journal = {Journal of Clinical Neurology},
year = {2026},
volume = {22},
number = {3},
pages = {384},
doi = {10.3988/jcn.2025.0695}
}
EUVIMED